Transforming growth factor-beta 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro.

The effects of transforming growth factor-beta 1 (TGF-beta 1) on normal rat palatal fibroblasts in vitro were investigated in the present study in order to unravel the precise mechanisms by which the phenotypic modulation of fibroblasts occurs during the scar formation process. TGF-beta 1 dramatically changed the morphology of normal palatal fibroblasts from polygonal into an elongated shape, which was very similar to that of fibroblasts derived from experimental immature scar tissue in rat palatal mucosa. This morphological transition was concomitant with an increase in the expression of alpha-smooth muscle (alpha-SM) actin protein, a marker for myofibroblasts, when determined by immunocytochemistry. An immunoblot study also revealed that alpha-SM actin expression in palatal fibroblasts became evident after 24 h of TGF-beta 1 treatment and increased time-dependently up to 72 h. Northern blot analysis showed that TGF-beta 1 stimulated endogenous TGF-beta 1 mRNA expression in palatal fibroblasts within 24 h. Neither epidermal growth factor nor basic fibroblast growth factor had any effect on either alpha-SM actin expression or TGF-beta 1 mRNA expression. Pretreatment of palatal fibroblasts with TGF-beta 1 significantly increased the contractile capacity in a three-dimensional collagen gel culture, even when the culture medium was deprived of TGF-beta 1 for 72 h of the experimental period. Moreover, the contractility of scar fibroblasts, which highly expressed alpha-SM actin protein and TGF-beta 1 mRNA, was significantly lowered by a neutralizing antibody to TGF-beta 1. These data strongly suggest that TGF-beta 1 is a potential inducer of phenotypic expression of myofibroblasts in palatal fibroblasts and that auto-induction of TGF-beta 1 mRNA expression may play an important role in the scar formation process in palatal mucosa.

[1]  K. Miyazono,et al.  Identification of Important Regions in the Cytoplasmic Juxtamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-β (*) , 1996, The Journal of Biological Chemistry.

[2]  L. Bonewald,et al.  Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein , 1995, The Journal of cell biology.

[3]  B. Chua,et al.  Myofibroblasts from Scleroderma Skin Synthesize Elevated Levels of Collagen and Tissue Inhibitor of Metalloproteinase (TIMP-1) with Two Forms of TIMP-1 (*) , 1995, The Journal of Biological Chemistry.

[4]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[5]  I. K. Cohen,et al.  Morphological and immunochemical differences between keloid and hypertrophic scar. , 1994, The American journal of pathology.

[6]  C. McCulloch,et al.  Dependence of collagen remodelling on α‐smooth muscle actin expression by fibroblasts , 1994 .

[7]  D. Volpin,et al.  Identification of a TGF-β Responsive Element in the Human Elastin Promoter , 1994 .

[8]  E. Ruoslahti,et al.  Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. , 1994, The Journal of clinical investigation.

[9]  F. Grinnell,et al.  Fibroblasts, myofibroblasts, and wound contraction , 1994, The Journal of cell biology.

[10]  A. Ghahary,et al.  Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues. , 1993, Journal of Laboratory and Clinical Medicine.

[11]  D. Hyde,et al.  Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. , 1993, Thorax.

[12]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[13]  O. Petersen,et al.  Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[14]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges. , 1992 .

[15]  A. Desmoulière,et al.  Heparin induces alpha-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[16]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[17]  D. J. Miletich,et al.  Progesterone Potentiation of Bupivacaine Arrhythmogenicity in Pentobarbital‐Anesthetized Rats and Beating Rat Heart Cell Cultures , 1992, Journal of cardiovascular pharmacology.

[18]  A. Desmoulière,et al.  α-Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon☆ , 1992 .

[19]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[20]  J. Lévêque,et al.  Measurement of mechanical forces generated by skin fibroblasts embedded in a three-dimensional collagen gel. , 1991, The Journal of investigative dermatology.

[21]  R. Timpl,et al.  Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. , 1991, The Journal of investigative dermatology.

[22]  K. Moriyama,et al.  Effects of growth factors on mucosal scar fibroblasts in culture--a possible role of growth factors in scar formation. , 1991, Matrix.

[23]  F. Grinnell,et al.  Stress relaxation of contracted collagen gels: disruption of actin filament bundles, release of cell surface fibronectin, and down-regulation of DNA and protein synthesis. , 1991, Experimental cell research.

[24]  G. Owens,et al.  Platelet‐derived growth factor‐induced destabilization of smooth muscle alpha‐actin mRNA , 1990, Journal of cellular physiology.

[25]  F. Grinnell,et al.  Spatial organization of extracellular matrix and fibroblast activity: effects of serum, transforming growth factor beta, and fibronectin. , 1990, Experimental cell research.

[26]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[27]  G. Gabbiani,et al.  Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[28]  J. Davidson,et al.  Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors , 1990, Journal of cellular physiology.

[29]  L. Madisen,et al.  Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2 , 1989, Molecular and cellular biology.

[30]  G. Gabbiani,et al.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells , 1989, The Journal of experimental medicine.

[31]  L. Orci,et al.  Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  W. Schürch,et al.  Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[33]  M. Sporn,et al.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene. , 1989, The Journal of biological chemistry.

[34]  M. Sporn,et al.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. , 1988, The Journal of biological chemistry.

[35]  W. Schürch,et al.  Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.

[36]  Murota Seiitsu,et al.  Comparison of arachidonic acid metabolism between myofibroblasts and fibroblasts isolated from rat palatal mucoperiosteum. , 1988 .

[37]  W. T. Chen,et al.  Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. , 1988, The Journal of biological chemistry.

[38]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.

[39]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[40]  B. Nusgens,et al.  The capacity of retracting a collagen matrix is lost by dermatosparactic skin fibroblasts. , 1983, The Journal of investigative dermatology.

[41]  B. Hull,et al.  Regulation of proliferation of fibroblasts of low and high population doubling levels grown in collagen lattices , 1981, Mechanisms of Ageing and Development.

[42]  C. Squier,et al.  Myofibroblasts in healing palatal wounds of the beagle dog. , 1980, Journal of anatomy.

[43]  A. Desmoulière,et al.  Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. , 1995, The American journal of pathology.

[44]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[45]  R. Eddy,et al.  Evidence for the nonmuscle nature of the "myofibroblast" of granulation tissue and hypertropic scar. An immunofluorescence study. , 1988, The American journal of pathology.

[46]  J. Vandekerckhove,et al.  Actin Typing on Total Cellular Extracts , 1981 .

[47]  G. Gabbiani,et al.  Myofibroblasts in human granulation tissue. , 1974, Human pathology.